Suppr超能文献

50岁以上人群中带状疱疹疫苗可接受性的评估:一项意大利观察性研究。

Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study.

作者信息

Valente Nicoletta, Lupi Silvia, Stefanati Armando, Cova Marisa, Sulcaj Najada, Piccinni Lucia, Gabutti Giovanni

机构信息

Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Department of Public Health, Ferrara Local Health Authority, Ferrara, Italy.

出版信息

BMJ Open. 2016 Oct 18;6(10):e011539. doi: 10.1136/bmjopen-2016-011539.

Abstract

OBJECTIVE

The aim of the study was to evaluate awareness of the varicella zoster virus and the acceptability of the newly available herpes zoster (HZ) vaccine in the over 50 years old general population.

DESIGN

The research was observational.

SETTING

The study was carried out in Ferrara by administering a questionnaire to patients of the Local Health Authority (LHA), general practitioners (GPs) and Public Health Department outpatient clinics.

PARTICIPANTS

The questionnaire was completed by 1001 residents of Ferrara Province.

RESULTS

Of the respondents, 98% and 95% (57% female) were aware of varicella and HZ, respectively, but 91% were unaware of the HZ vaccine. Nevertheless, 58% declared that they were in favour of vaccination in this regard, and the acceptability of the vaccine was positively affected by: age (p=0.005); knowing someone who had suffered from HZ (p=0.05); being in favour of vaccination in general (p<0.0001); receiving advice to do so from their GP (p<0.0001) and willingness to get vaccinated even on a fee-paying basis (p<0.0001). Indeed, most (73%) respondents were willing to pay to get vaccinated, indicating an ideal cost of €50. Higher education (p=0.04), being in favour of vaccinations in general (p<0.0001) and GP advice (p<0.0001) positively affected this choice. Furthermore, 61% of the participants initially unfavourable (p<0.0001) to this immunisation would change their decision not to vaccinate thanks to their GP's advice.

CONCLUSIONS

This study assessed the level of awareness and the attitudes of the population aged over 50 years, highlighting aspects to be focused on in the promotion of the HZ vaccine.

摘要

目的

本研究旨在评估50岁以上普通人群对水痘带状疱疹病毒的认知以及对新上市的带状疱疹(HZ)疫苗的接受程度。

设计

本研究为观察性研究。

地点

该研究在费拉拉进行,通过向当地卫生当局(LHA)的患者、全科医生(GPs)和公共卫生部门门诊发放问卷来开展。

参与者

费拉拉省的1001名居民完成了问卷。

结果

在受访者中,分别有98%和95%(57%为女性)知晓水痘和HZ,但91%不知道HZ疫苗。然而,58%表示他们赞成在这方面进行疫苗接种,疫苗的可接受性受到以下因素的积极影响:年龄(p = 0.005);认识患过HZ的人(p = 0.05);总体上赞成接种疫苗(p < 0.0001);从全科医生处得到接种建议(p < 0.0001)以及即使付费也愿意接种疫苗(p < 0.0001)。实际上,大多数(73%)受访者愿意付费接种疫苗,理想费用为50欧元。高等教育程度(p = 0.04)、总体上赞成接种疫苗(p < 0.0001)和全科医生的建议(p < 0.0001)对这一选择有积极影响。此外,61%最初不赞成(p < 0.0001)这种免疫接种的参与者会因全科医生的建议而改变不接种的决定。

结论

本研究评估了50岁以上人群的认知水平和态度,突出了在推广HZ疫苗时应关注的方面。

相似文献

2
Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.
Hum Vaccin Immunother. 2015;11(3):719-26. doi: 10.1080/21645515.2015.1008885.
3
Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly.
Vaccine. 2009 Jan 7;27(2):192-6. doi: 10.1016/j.vaccine.2008.10.047. Epub 2008 Nov 7.
5
Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
Vaccine. 2014 Sep 29;32(43):5749-54. doi: 10.1016/j.vaccine.2014.08.040. Epub 2014 Aug 27.
7
Acceptability and perception of the herpes zoster vaccine in the 65 and over population: A French observational study.
Vaccine. 2020 Aug 18;38(37):5891-5895. doi: 10.1016/j.vaccine.2020.07.004. Epub 2020 Jul 21.
9
Willingness to vaccinate against herpes zoster in Chinese urban population: a mixed-methods study.
BMJ Open. 2023 Dec 7;13(12):e079115. doi: 10.1136/bmjopen-2023-079115.
10
Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.
BMC Infect Dis. 2017 Mar 15;17(1):213. doi: 10.1186/s12879-017-2198-y.

引用本文的文献

1
Awareness and acceptability of herpes zoster vaccination in people living with HIV.
Prev Med Rep. 2025 Jun 16;56:103143. doi: 10.1016/j.pmedr.2025.103143. eCollection 2025 Aug.
5
Vaccine uptake, associated factors and reasons for vaccination status among the South African elderly; findings and next steps.
PLoS One. 2024 Dec 4;19(12):e0314098. doi: 10.1371/journal.pone.0314098. eCollection 2024.
6
Understanding invisible pain in the older adult: a content analysis of social media's representation of herpes zoster vaccine.
Front Public Health. 2024 Jul 23;12:1420349. doi: 10.3389/fpubh.2024.1420349. eCollection 2024.
9
Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy.
Vaccines (Basel). 2024 Jan 3;12(1):51. doi: 10.3390/vaccines12010051.

本文引用的文献

1
Cost Effectiveness Analysis of A Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Italy.
Value Health. 2014 Nov;17(7):A511. doi: 10.1016/j.jval.2014.08.1572. Epub 2014 Oct 26.
2
Vaccination against zoster remains effective in older adults who later undergo chemotherapy.
Clin Infect Dis. 2014 Oct;59(7):913-9. doi: 10.1093/cid/ciu498. Epub 2014 Aug 4.
3
Varicella and herpes zoster vaccines: WHO position paper, June 2014.
Wkly Epidemiol Rec. 2014 Jun 20;89(25):265-87.
4
Systematic review of incidence and complications of herpes zoster: towards a global perspective.
BMJ Open. 2014 Jun 10;4(6):e004833. doi: 10.1136/bmjopen-2014-004833.
5
The variegate neurological manifestations of varicella zoster virus infection.
Curr Neurol Neurosci Rep. 2013 Sep;13(9):374. doi: 10.1007/s11910-013-0374-z.
7
Similar herpes zoster incidence across Europe: results from a systematic literature review.
BMC Infect Dis. 2013 Apr 10;13:170. doi: 10.1186/1471-2334-13-170.
9
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.
Clin Infect Dis. 2012 Apr;54(7):922-8. doi: 10.1093/cid/cir970. Epub 2012 Jan 30.
10
Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study.
Infection. 2011 Dec;39(6):537-44. doi: 10.1007/s15010-011-0162-0. Epub 2011 Jul 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验